About the Authors
- Jennifer S. Carew
-
Affiliation Department of Medicine and Institute for Drug Development, Cancer Therapy and Research Center at The University of Texas Health Science Center, San Antonio, Texas, United States of America
- Juan A. Esquivel II
-
Affiliation Department of Medicine and Institute for Drug Development, Cancer Therapy and Research Center at The University of Texas Health Science Center, San Antonio, Texas, United States of America
- Claudia M. Espitia
-
Affiliation Department of Medicine and Institute for Drug Development, Cancer Therapy and Research Center at The University of Texas Health Science Center, San Antonio, Texas, United States of America
- Christoph M. Schultes
-
Affiliation Elara Pharmaceuticals GmbH, Heidelberg, Germany
- Marcel Mülbaier
-
Affiliation Elara Pharmaceuticals GmbH, Heidelberg, Germany
- Joe D. Lewis
-
Affiliation Elara Pharmaceuticals GmbH, Heidelberg, Germany
- Bernd Janssen
-
Affiliation Elara Pharmaceuticals GmbH, Heidelberg, Germany
- Francis J. Giles
-
Affiliation Department of Medicine and Institute for Drug Development, Cancer Therapy and Research Center at The University of Texas Health Science Center, San Antonio, Texas, United States of America
- Steffan T. Nawrocki
-
* E-mail: Nawrocki@uthscsa.edu
Affiliation Department of Medicine and Institute for Drug Development, Cancer Therapy and Research Center at The University of Texas Health Science Center, San Antonio, Texas, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: JC SN. Performed the experiments: JC JE CE SN. Analyzed the data: JC CE SN. Contributed reagents/materials/analysis tools: CS MM JL BJ FG. Wrote the paper: JC SN.